Prosecution Insights
Last updated: October 04, 2026

Jiangsu Biojetay Biotechnology Co. Ltd.

1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Jiangsu Biojetay Biotechnology Co. Ltd. has 1 pending office action currently active in its patent portfolio. This matter is assigned to 1 distinct examiner, LU, CHENG, who is also the busiest examiner with 1 busiest examiner pending case. The data shows 0 distinct art units associated with this prosecution activity. This suggests a very narrow or early-stage filing status where the case has not yet been broadly distributed across the patent office's technical divisions.

The presence of the 1 pending office action handled by the 1 distinct examiner reflects a singular point of contact for the company's current legal proceedings. Since LU, CHENG holds the 1 busiest examiner pending case, the prosecution strategy is entirely dependent on the specific requirements of this individual examiner. Given the 0 distinct art units listed, the procedural path for this application remains highly concentrated. The company's immediate success in securing patent rights is tied to the resolution of the current matter.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Double-patenting + other1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
100% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
LU, CHENG 1 54.1% +64.1%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18681232 ANTIBODIES SPECIFICALLY RECOGNIZING FCRN AND USES THEREOF LU, CHENG —

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18681232 ANTIBODIES SPECIFICALLY RECOGNIZING FCRN AND USES THEREOF LU, CHENG — §112DP Non-Final OA — Pending Feb 05, 2024

Managing Jiangsu Biojetay Biotechnology Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month